Physicians news and physicians widget

Data presented today at the American College of Allergy, Asthma & Immunology (ACAAI) show that Xolair (Omalizumab) for Subcutaneous Use significantly reduced asthma attacks in children aged six through 11 with moderate or severe persistent allergic asthma inadequately controlled with inhaled corticosteroids.

HIV is a master of disguise, able to rapidly change its identity and hide undetected in infected cells.

According to the National Institute of Mental health, one in 17 Americans suffer from serious mental illness. Four new memoirs ...

Scientists have thought that one way to foil a tumor from generating blood vessels to feed its growth - a process called angiogenesis - was by creating drugs aimed at stopping a key vessel growth-promoting protein.

Like many young adults today, Emily and Joe Becker waited to marry until they felt the time was right. Others are also holding ...

An international trial found that the cholesterol busting drug rosuvastatin reduced heart attack and stroke in men and women with low cholesterol who had high levels of C-reactive protein but who were otherwise classed as healthy, and experts suggested this could be a class effect of all statins and not just which is marketed by AstraZeneca as Crestor.

In examining health inequalities between the rich and the poor, the gap becomes narrower in areas with the greenest environments, according to an article released on November 7, 2008 in The Lancet.

In patients with type 2 diabetes, low-dose aspirin does not appear to significantly reduce the risk of endpoints including coronary, cerebrovascular, and peripheral vascular events, according to a report released on November 9, 2008 in JAMA, to coincide with the results' presentation at the American Heart Association (AHA) meeting.

America's veterinarians today congratulated their fellow veterinarian and small business owner, Dr. Kurt Schrader, on his successful election to the United States House of Representatives. On Tuesday, Dr. Schrader (D) was elected to represent Oregon's 5th Congressional District. Dr.

KMR GROUP, a firm analyzing biopharmaceutical R&D performance, announces the launch of a Discovery study to assess research performance and identify trends that promise to shape the most successful Discovery organizations of the future. The study is part of the Pharmaceutical Benchmarking Forum's initiatives for 2009 and already has a number of major company participants.